Kindstar Globalgene Technology Inc. (Kindstar Global) reported a share repurchase of 12,500 ordinary shares on 15 June 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

The shares were bought on-market at prices ranging from HKD 0.98 to HKD 1.01, for a total consideration of HKD 12,350, or an average of HKD 0.99 per share. All repurchased shares have been retained as treasury stock.

Post-transaction, Kindstar Global’s issued share capital (excluding treasury shares) declined from 1,034.14 million to 1,034.12 million, a marginal reduction of 0.00121%. Treasury shares increased to 7.20 million, while the company’s total issued shares remained unchanged at 1,041.33 million.

The buyback was executed under a mandate approved on 5 June 2026 that authorises the company to repurchase up to 103.43 million shares. Cumulative repurchases under this mandate now stand at 139,000 shares, equivalent to 0.13% of the authorised limit and 0.01344% of issued shares outstanding at the mandate date.

In line with Hong Kong listing rules, Kindstar Global is subject to a moratorium on issuing new shares or disposing of treasury shares until 15 July 2026.